Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,499Revenue (TTM) $M4,431Net Margin (%)13.4Altman Z-Score1.6
Enterprise Value $M6,375EPS (TTM) $1.3Operating Margin %23.9Piotroski F-Score6
P/E(ttm)16.6Beneish M-Score-2.6Pre-tax Margin (%)17.6Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %29.7Current Ratio3.0Lower Leverage y-yY
Price/Free Cash Flow117y-y EBITDA Growth Rate %9.0ROA % (ttm)5.7Higher Current Ratio y-yY
Dividend Yield %2.2PEG0.6ROE % (ttm)16.5Less Shares Outstanding y-yY
Payout Ratio %41.0Shares Outstanding M342ROIC % (ttm)14.2Gross Margin Increase y-yN

Gurus Latest Trades with GRFS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GRFSJohn Paulson 2016-06-30 Reduce-1.2%$14.54 - $17.3
($15.72)
$ 16.092%Reduce -58.11%7,345,166
GRFSMario Gabelli 2016-06-30 Reduce$14.54 - $17.3
($15.72)
$ 16.092%Reduce -2.79%55,800
GRFSJohn Paulson 2016-03-31 Reduce-0.72%$14.2 - $16.2
($15.14)
$ 16.096%Reduce -29.29%17,533,764
GRFSRon Baron 2016-03-31 Add$14.2 - $16.2
($15.14)
$ 16.096%Add 7.14%75,000
GRFSJohn Paulson 2015-12-31 Add0.7%$15.84 - $17.79
($16.91)
$ 16.09-5%Add 39.86%24,796,280
GRFSMario Gabelli 2015-12-31 Add0.01%$15.84 - $17.79
($16.91)
$ 16.09-5%Add 119.08%57,400
GRFSRon Baron 2015-12-31 Add0.01%$15.84 - $17.79
($16.91)
$ 16.09-5%Add 100.00%70,000
GRFSJohn Paulson 2015-09-30 Reduce-0.01%$14.75 - $16.78
($15.87)
$ 16.091%Reduce -0.52%35,458,280
GRFSRon Baron 2015-09-30 Add$14.75 - $16.78
($15.87)
$ 16.091%Add 6.06%70,000
GRFSMario Gabelli 2015-09-30 Reduce$14.75 - $16.78
($15.87)
$ 16.091%Reduce -13.25%52,400
GRFSMario Gabelli 2015-06-30 Add$15.2 - $17.43
($16.22)
$ 16.09-1%Add 8.37%60,400
GRFSRon Baron 2015-06-30 Reduce$15.2 - $17.43
($16.22)
$ 16.09-1%Reduce -12.70%66,000
GRFSJohn Paulson 2015-06-30 Add$15.2 - $17.43
($16.22)
$ 16.09-1%Add 0.11%35,642,080
GRFSJohn Paulson 2015-03-31 Add$15.69 - $17.78
($16.74)
$ 16.09-4%Add 0.05%35,603,480
GRFSMario Gabelli 2015-03-31 Add$15.69 - $17.78
($16.74)
$ 16.09-4%Add 16.27%55,736
GRFSJohn Paulson 2014-12-31 Reduce-0.27%$14.89 - $18.62
($17.21)
$ 16.09-7%Reduce -9.25%35,584,280
GRFSMario Gabelli 2014-12-31 Reduce$14.89 - $18.62
($17.21)
$ 16.09-7%Reduce -4.80%47,936
GRFSRon Baron 2014-12-31 Reduce$14.89 - $18.62
($17.21)
$ 16.09-7%Reduce -11.68%75,600
GRFSJohn Paulson 2014-06-30 Reduce-0.04%$18.32 - $23.22
($20.92)
$ 16.09-23%Reduce -1.06%39,210,362
GRFSRon Baron 2014-06-30 Reduce$18.32 - $23.22
($20.92)
$ 16.09-23%Reduce -4.37%85,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GRFS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GRFS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about GRFS:

    News about GRFS:

    Articles On GuruFocus.com
    John Paulson Raises Stake in Valeant, Teva Pharmaceutical Mar 18 2016 
    Gold-Focused Guru John Paulson Reports First Quarter Holdings May 22 2014 
    Is Grifols Being Overlooked? Mar 19 2014 
    John Paulson's Top Five Holdings Nov 20 2013 
    John Paulson's Top Five Holdings Sep 12 2013 
    Baron Funds Comments on Grifols SA Aug 30 2012 
    Friday Value Overview Aug 19 2011 

    More From Other Websites
    5 Big Dividend Stocks Billionaire John Paulson Loves Sep 08 2016
    Grifols Opens Diagnostic Training Center in Dubai Sep 05 2016
    Grifols Opens Diagnostic Training Center in Dubai Sep 05 2016
    New Zika Screening Rule Could Boost Hologic Sales Growth Aug 26 2016
    ETF’s with exposure to Grifols SA : August 25, 2016 Aug 25 2016
    Grif_ls support the Canadian Blood Services' Missing Type Campaign Aug 16 2016
    The results of phase I clinical trial of the Araclon Biotech Alzheimer's vaccine support its... Aug 01 2016
    Sales of the Bioscience Division grow by +7.0%, increasing Grifols' revenues by +2.7% to EUR 1,952... Jul 28 2016
    Sales of the Bioscience Division grow by +7.0%, increasing Grifols’ revenues by +2.7% to EUR 1,952... Jul 28 2016
    Award Winners of the 9th Annual Martín Villar Haemostasis Awards Jul 27 2016
    Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : July 26, 2016 Jul 26 2016
    ETF’s with exposure to Grifols SA : July 25, 2016 Jul 25 2016
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12,... Jul 12 2016
    Pedigri®: the tool that increases the information transparency to the plasma-derived manufactured... Jul 05 2016
    ETF’s with exposure to Grifols SA : June 30, 2016 Jun 30 2016
    Award Winners of the 9th Annual Martín Villar Haemostasis Awards Jun 30 2016
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : June 29,... Jun 29 2016
    Award Winner of the 2016 SPIN Awards Program Jun 29 2016
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016 Jun 22 2016
    Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 Jun 22 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)